<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[compound Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/compound.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to compound]]></description>
	<s:counts start="0" returned="20" found="610" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Adolor Corp. Q3 2009 Earnings Conference Call]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-358483.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  At this time we will take questions that you may have. Operator Instructions. First question comes from Charles Inaudible of Prime Investments. Please proceed.  Unidentified Analyst  Thank you very much great job on the numbers out there gentlemen great job, looks great. Just...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 29 Oct 2009 07:06:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/adolor+corp..html"><![CDATA[Adolor Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/recruitment+%2526+selection.html"><![CDATA[Recruitment & Selection]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADLR</category>
		<category domain="tickers">ADLR</category>
	</item>
	<item>
		<title><![CDATA[Adolor Corporation Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-325921.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Your first question comes from Ian Sanderson of Cowen and Company. Ian Sanderson &#8211; Cowen and Company Good morning, thank you for taking the question. First on ENTEREG, if you get further into the process, the formulary negotiation process with hospitals what has been I...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 29 Jul 2009 08:42:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/food.html"><![CDATA[Food]]></category>
		<category domain="http://resources.bnet.com/topic/hospital.html"><![CDATA[Hospital]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/dissolution.html"><![CDATA[Dissolution]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/food+%2526+beverage.html"><![CDATA[Food & Beverage]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/adolor+corp..html"><![CDATA[Adolor Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADLR</category>
		<category domain="tickers">ADLR</category>
	</item>
	<item>
		<title><![CDATA[Exelixis Inc Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-275782.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions.  Your first question comes from the line of Eric Schmidt with Cowen and Company. Eric Schmidt &#8211; Cowen and Company  I think it was actually Frank who mentioned that you re-triggered some of the phase I studies on 228, 888, and 019 to...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 04 Mar 2009 18:01:28 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/eric+schmidt.html"><![CDATA[Eric Schmidt]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/exelixis+inc..html"><![CDATA[Exelixis Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EXEL</category>
		<category domain="tickers">EXEL</category>
	</item>
	<item>
		<title><![CDATA[CombinatoRx, Inc., Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-275596.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instructions.  Our first question comes from the line of Gregory Wade - Wedbush Morgan Securities. Gregory Wade - Wedbush Morgan Securities With respect to the burn guidance, $5 million to $10 million kind of a large range, if you could just provide some...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 04 Mar 2009 10:56:10 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/deliverable.html"><![CDATA[Deliverable]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[Analysis]]></category>
		<category domain="http://resources.bnet.com/topic/combinatorx+inc..html"><![CDATA[CombinatoRx Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[Collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/groupware.html"><![CDATA[Groupware]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRXX</category>
		<category domain="tickers">CRXX</category>
	</item>
	<item>
		<title><![CDATA[Lexicon Pharmaceuticals Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-273048.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first questions come from Jason Cantor from RBC Capital Markets. Jason Cantor - RBC Capital Markets Great, thanks for taking the question and thanks for update on the pipeline. Could you add to the discussion on the pipeline products what you&#8217;ve seen in terms...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 25 Feb 2009 13:52:15 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/evidence.html"><![CDATA[Evidence]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/rbc+capital+markets.html"><![CDATA[RBC Capital Markets]]></category>
		<category domain="http://resources.bnet.com/topic/lexicon+pharmaceuticals+inc..html"><![CDATA[Lexicon Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LXRX</category>
		<category domain="tickers">LXRX</category>
	</item>
	<item>
		<title><![CDATA[Cytokinetics, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-267685.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Your first question comes from Mark Monane with Needham. Your line is open. Mark Monane &#8211; Needham Hi, thank you. Good afternoon. And thank you for the reviewing 2008 and look into 2009 in this fine afternoon in New York City. Robert Blum Good afternoon,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Tue, 10 Feb 2009 18:22:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/muscle.html"><![CDATA[Muscle]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/needham.html"><![CDATA[Needham]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/cytokinetics.html"><![CDATA[Cytokinetics]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTK</category>
		<category domain="tickers">CYTK</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: ImClone a Done Deal, FDA Approvals Up, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000418/pharma-roundup-imclone-a-done-deal-fda-approvals-up-and-more/]]></link>
		<description><![CDATA[ImClone leaving the headlines at last, perhaps; FDA beats last year's approval rate, despite a string of delays; a good biotech merger for a bad economy. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 21 Nov 2008 16:19:47 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/archemix.html"><![CDATA[Archemix]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
	</item>
	<item>
		<title><![CDATA[Cleveland BioLabs: Robust Pipeline, Attractive Valuation]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F106582-cleveland-biolabs-robust-pipeline-attractive-valuation%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Cleveland BioLabs, Inc. CBLI is a drug discovery and development company, utilizing its discoveries regarding apoptosis to treat cancer and protect normal tissues from exposure to radiation and other stresses. The company is developing its compounds for Biodefense, treatment of cancer and tissue protection due to...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 18 Nov 2008 05:02:26 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/valuation.html"><![CDATA[Valuation]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/branding.html"><![CDATA[Branding]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/cleveland+biolabs+inc..html"><![CDATA[Cleveland BioLabs Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBLI</category>
		<category domain="tickers">CBLI</category>
	</item>
	<item>
		<title><![CDATA[Albany Molecular Research, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-250163.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions. We'll take our first question from Dave Windley with Jefferies. David Windley &#8211; Jefferies & Co.  Hi, good morning. Thanks for taking the questions and congratulations on managing through tough environment here. Wondering on your BMS and access fee amortization and funded research, I...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Tue, 18 Nov 2008 03:37:11 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/albany+molecular+research+inc..html"><![CDATA[Albany Molecular Research Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
		<category domain="tickers">AMRI</category>
	</item>
	<item>
		<title><![CDATA[Onyx's $320M Bet on BTG's Anticancer Compound]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F105088-onyx-s-320m-bet-on-btg-s-anticancer-compound%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Eben Tessari submits:  BTG has granted the worldwide commercialization and development rights of BGC 945, a novel anticancer compound, to Onyx ONXX in exchange for a potential $320M.  BGC 945 is a novel compound that inhibits thymidylate synthase (TS), an enzyme involved in cell growth and division. However,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 10 Nov 2008 09:53:10 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/onyx+software.html"><![CDATA[Onyx Software]]></category>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[Cell]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/bgc+945.html"><![CDATA[BGC 945]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/onyx+pharmaceuticals+inc..html"><![CDATA[Onyx Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ONXX</category>
		<category domain="tickers">ONXX</category>
	</item>
	<item>
		<title><![CDATA[Array BioPharma F1Q09 (Qtr End 09/30/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-246344.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you, sir.  Operator Instructions.  We&#8217;ll take our first question from Jim Birchenough with Barkley&#8217;s Capital.   Jim Birchenough &#8211; Barclays Capital  Hi guys, congratulations on the progress this year.   Bob Conway  Thank you.   Jim Birchenough &#8211; Barclays...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Tue, 04 Nov 2008 09:51:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/efficacy.html"><![CDATA[Efficacy]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/efficacy.html"><![CDATA[Efficacy]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/array+biopharma+inc..html"><![CDATA[Array BioPharma Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARRY</category>
		<category domain="tickers">ARRY</category>
	</item>
	<item>
		<title><![CDATA[Nventa Biopharmaceuticals Wall Street Analyst Forum Presentation Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-223411.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionUnidentified Audience Member Question Inaudible Richard Lai Fatt We will we are actually in the process, that is why.  Richard Lai Fatt Sorry. To repeat the question, how do we tend to keep the company going with the current finances? We have $8 million there and of...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 10 Sep 2008 10:41:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[Compound]]></category>
		<category domain="http://resources.bnet.com/topic/transcript.html"><![CDATA[Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
	</item>
	<item>
		<title><![CDATA[Statin snag]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m1200/is_4_174/ai_n28028637]]></link>
		<description><![CDATA[Cholesterol-reducing drugs called statins do their job with remarkable efficiency, but in rare cases they can cause serious muscle pain, called myopathy. In the August 21 New England Journal of Medicine, researchers will report the discovery of a variant in the gene SLCO1B1 that places people at risk. The variant...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 16 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cholesterol.html"><![CDATA[cholesterol]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+oxford.html"><![CDATA[University of Oxford]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Community meeting Wednesday on Cal-Tech clean up]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4176/is_20080805/ai_n28038638]]></link>
		<description><![CDATA[The Alameda County Public Health Department and city officials are holding a community meeting today to discuss the cleanup activity that will soon take place at the old Cal-Tech Metal Finishers site at 841 31st St. in West Oakland.   The meeting is being presented by the health department,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 05 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+environmental+protection+agency.html"><![CDATA[U.S. Environmental Protection Agency]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[EPA publishes reactivity rule for Aerosol Coatings]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb053/is_8_13/ai_n29457823]]></link>
		<description><![CDATA[The EPA's new final rule for National Volatile Organic Compound VOC Emission Standards for Aerosol Coatings pares down the Table of Reactivity Factors from over 800 compounds to approximately 40 compounds. It defines product categories and the Table of Standards in a manner that mirrors the current California reactivity regulation....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/california.html"><![CDATA[California]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+environmental+protection+agency.html"><![CDATA[U.S. Environmental Protection Agency]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[EPA tests show no danger in West Oakland]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4176/is_20080729/ai_n28061056]]></link>
		<description><![CDATA[OAKLAND -- A neighborhood in West Oakland can breathe easier after tests for dangerous levels of hazardous compounds in the air came back negative, according to federal environmental officials.   On Friday, the U.S. Environmental Protection Agency tested about a half-dozen homes, a business and a day care center...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 29 Jul 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+environmental+protection+agency.html"><![CDATA[U.S. Environmental Protection Agency]]></category>
		<category domain="http://resources.bnet.com/topic/vapor.html"><![CDATA[vapor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[At least 15 killed in Afghanistan during hunt for militants]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200806/ai_n26680484]]></link>
		<description><![CDATA[KABUL AFP &#8212; More than 15 insurgents were killed in Afghanistan as security forces hunted for hundreds of militants who escaped from prison after a daring Taliban attack, police and troops said Sunday.  Afghan and international troops have been searching for more than 1,100 escapees who fled after the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 15 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/afghanistan.html"><![CDATA[Afghanistan]]></category>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/attack.html"><![CDATA[attack]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Life cycle inventory of the automotive paint processes]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3226/is_6_5/ai_n29460041]]></link>
		<description><![CDATA[Automotive coating processes contribute significantly to the environmental burden of vehicle manufacturing, with significant emissions released to air, water, and land, and consumption of substantial amounts of energy and raw materials. In North America, the automotive industry is currently quantifying the environmental impacts incurred during an automobile's manufacturing processes. Detailed...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 01 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/annual.html"><![CDATA[Annual]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/database.html"><![CDATA[database]]></category>
		<category domain="http://resources.bnet.com/topic/emission.html"><![CDATA[emission]]></category>
		<category domain="http://resources.bnet.com/topic/environmental.html"><![CDATA[Environmental]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/national+renewable+energy+laboratory.html"><![CDATA[National Renewable Energy Laboratory]]></category>
		<category domain="http://resources.bnet.com/topic/oem.html"><![CDATA[OEM]]></category>
	</item>
	<item>
		<title><![CDATA[USDA looks for next-generation insect repellent: study]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200805/ai_n25458780]]></link>
		<description><![CDATA[CHICAGO AFP &#8212; American researchers have identified several new potential insect repellants that are three times more potent than DEET, the active ingredient in most tick and insect repellents, a study released Monday said.  In laboratory tests, the new compounds protected human volunteers from mosquitoes two to three times...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 26 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/productivity.html"><![CDATA[PRODUCTIVITY]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+agriculture.html"><![CDATA[U.S. Department of Agriculture]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[USDA looks for next-generation insect repellent]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200805/ai_n25458796]]></link>
		<description><![CDATA[CHICAGO AFP &#8212; American researchers have identified several new potential insect repellants that are three times more potent than DEET, the active ingredient in most tick and insect repellents, according to a new study.  In laboratory tests, the new compounds protected human volunteers from mosquitoes two to three times...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 26 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/productivity.html"><![CDATA[PRODUCTIVITY]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+agriculture.html"><![CDATA[U.S. Department of Agriculture]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
